B cells recruited into splenic antibody responses grow exponentially, either in extrafollicular foci as plasmablasts, or in follicles where they form germinal centers. Both responses yield plasma cells. Although many splenic plasma cells survive <3 d, some live much longer. This study shows that early plasma cell death relates to a finite capacity of the spleen to sustain plasma cells rather than a life span endowed by the cell's origin or the quality of antibody it produces. Antibody responses were compared where the peak numbers of plasma cells in spleen sections varied between 100 and 5,000 cells/mm2. In each response, plasmablast clones divided some five times, with the peak numbers of plasma cells produced relating directly to the number of B cells recruited into the response. The spleen seems to have the capacity to sustain between 20 and 100 plasma cells/mm2. When this number is exceeded, there is a loss of excess cells. Immunoglobulin variable region gene sequencing, and 5-bromo-2′-deoxyuridine pulse–chase studies indicate that long-lived splenic plasma cells are a mixture of cells derived from the extrafollicular and germinal center responses and cells derived from virgin and memory B cells. Only a proportion has switched immunoglobulin class.
Skip Nav Destination
Article navigation
18 September 2000
Article|
September 11 2000
Intrinsic Constraint on Plasmablast Growth and Extrinsic Limits of Plasma Cell Survival
Daniel M.-Y. Sze,
Daniel M.-Y. Sze
aUniversity of Birmingham/Medical Research Council Centre for Immune Regulation, The University of Birmingham Medical School, Birmingham B15 2TT, United Kingdom
Search for other works by this author on:
Kai-Michael Toellner,
Kai-Michael Toellner
aUniversity of Birmingham/Medical Research Council Centre for Immune Regulation, The University of Birmingham Medical School, Birmingham B15 2TT, United Kingdom
Search for other works by this author on:
Carola García de Vinuesa,
Carola García de Vinuesa
aUniversity of Birmingham/Medical Research Council Centre for Immune Regulation, The University of Birmingham Medical School, Birmingham B15 2TT, United Kingdom
Search for other works by this author on:
Dale R. Taylor,
Dale R. Taylor
aUniversity of Birmingham/Medical Research Council Centre for Immune Regulation, The University of Birmingham Medical School, Birmingham B15 2TT, United Kingdom
Search for other works by this author on:
Ian C.M. MacLennan
Ian C.M. MacLennan
aUniversity of Birmingham/Medical Research Council Centre for Immune Regulation, The University of Birmingham Medical School, Birmingham B15 2TT, United Kingdom
Search for other works by this author on:
Daniel M.-Y. Sze
aUniversity of Birmingham/Medical Research Council Centre for Immune Regulation, The University of Birmingham Medical School, Birmingham B15 2TT, United Kingdom
Kai-Michael Toellner
aUniversity of Birmingham/Medical Research Council Centre for Immune Regulation, The University of Birmingham Medical School, Birmingham B15 2TT, United Kingdom
Carola García de Vinuesa
aUniversity of Birmingham/Medical Research Council Centre for Immune Regulation, The University of Birmingham Medical School, Birmingham B15 2TT, United Kingdom
Dale R. Taylor
aUniversity of Birmingham/Medical Research Council Centre for Immune Regulation, The University of Birmingham Medical School, Birmingham B15 2TT, United Kingdom
Ian C.M. MacLennan
aUniversity of Birmingham/Medical Research Council Centre for Immune Regulation, The University of Birmingham Medical School, Birmingham B15 2TT, United Kingdom
Abbreviations used in this paper: BrdU, 5-bromo-2′-deoxyuridine; CGG, chicken gamma globulin; NP, (4-hydroxy-3-nitrophenyl) acetyl; QM, quasimonoclonal.
Received:
October 25 1999
Revision Requested:
July 28 2000
Accepted:
August 07 2000
Online ISSN: 1540-9538
Print ISSN: 0022-1007
© 2000 The Rockefeller University Press
2000
The Rockefeller University Press
J Exp Med (2000) 192 (6): 813–822.
Article history
Received:
October 25 1999
Revision Requested:
July 28 2000
Accepted:
August 07 2000
Citation
Daniel M.-Y. Sze, Kai-Michael Toellner, Carola García de Vinuesa, Dale R. Taylor, Ian C.M. MacLennan; Intrinsic Constraint on Plasmablast Growth and Extrinsic Limits of Plasma Cell Survival. J Exp Med 18 September 2000; 192 (6): 813–822. doi: https://doi.org/10.1084/jem.192.6.813
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement